Schmidt, Annette Otto, Kai Heinecke, Jördis Bax-Knoche, Carmela Beger, Sarah Becker, Stephan Bartels , Tim Ripperger, Jens Bohne, Thilo Dörk, Brigitte Schlegelberger, Winfried Hofmann, Doris Steinemann. Human

Shrestha M, Baraki H, Khaladj N, Koigeldiyev N, Haverich A, Hagl C: Do Patients Profit from Third Time CABG? Open J Cardiovasc Surg 2009; no. 2:1-5. Tudorache I, Kostin S, Meyer T, Teebken O, Bara C, Hilfiker

gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis Kathrin Haake, Tim Wüstefeld, Sylvia Merkert, Doreen Lüttge, Gudrun Göhring, Bernd Auber, Ulrich Baumann, Nico Lachmann

Opdam FJ, Patterson SD, Patton S, Pinto C, Rouleau E, Schuuring E, Sterck S, Taron M, Tejpar S, Timens W, Thunnissen E, van de Ven PM, Siebers AG, Dequeker E: Guideline on the requirements of external

Forum 2024; 32(3): 181–185 Mathes T, Röding D , Stegbauer C, Laxy M, Pieper D (2024). Interrupted Time Series for Assessing the Causality of Intervention Effects. Part 35 of a Series on Evaluating Scientific

Schildhaus HU, Schirmacher P, Serre I, Shaw E, Sizaret D, Stenzinger A, Stojsic J, Thunnissen E, Timens W, Troncone G, Werlein C , Wolff H, Berthet JP, Benzaquen J, Marquette CH, Hofman V, Calabrese F [...] Haller H, Gueler F, Greite R, Derlin K. Diffusion-Weighted Imaging and Mapping of T1 and T2 Relaxation Time for Evaluation of Chronic Renal Allograft Rejection in a Translational Mouse Model. J Clin Med. 2021

Kleine-Döpke D , Neubert L, Ross TL, Ringe BP, Schmelzle M , Bengel FM. Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism [...] Leiskau C, Vondran FWR , Richter N , D'Antiga L, Mikolajczyk R, Pfister ED, Baumann U. Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Re [...] Klempnauer J , Kleine M . Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg. 2020 F

AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Neuro Oncol 2017; 19(8): 1088-1096 Zhang R, Mägel L , Jonigk D , Länger F , Lippmann

Schoenfeld, Jan C Wüstenfeld, Tom Kastner, Friedrich Barsch, Birgit Friedmann-Bette, Wilhelm Bloch, Tim Meyer, Frank Mayer, Bernd Wolfarth, Kai Roecker, Claus Reinsberger, Bernhard Haller, Andreas M Niess;